tiprankstipranks
Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys” – 6/7/2024 
Market News

Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys” – 6/7/2024 

TipRanks’ Technical Analysis Screener  gives investors everything they need to find the stocks that fit their unique technical analysis investment strategy. Using the screener, we have identified three stocks that are considered Strong Buys according to both their technical analysis score and Wall Street analysts’ ratings.

Pick the best stocks and maximize your portfolio:

Here are this week’s stocks: 

CrowdStrike (NASDAQ:CRWD– CRWD is a cybersecurity company known for its cloud-native endpoint protection platform that detects and prevents threats in real-time. CRWD stock carries a Strong Buy overall technical analysis score. Analysts concur with that sentiment, giving a Strong Buy consensus rating with a 12-month price target that implies an upside of about 18%.

Synopsys (NASDAQ:SNPS) – SNPS is a software company that develops electronic products and applications. The stock has a Strong Buy overall technical analysis score. Likewise, analysts have given SNPS stock a Strong Buy consensus rating, with a 12-month price target indicating about a 13% upside on the stock.

Merck (NYSE:MRK) – This global healthcare company develops pharmaceuticals, vaccines, biologic therapies, and animal health products. The stock has a Strong Buy overall technical analysis score. Likewise, analysts have given the stock a Strong Buy consensus rating, with a 12-month price target indicating about 9% upside potential.

What Is the TipRanks Technical Analysis Score? 

TipRanks’ unique calculation combines the Moving Average score and the Oscillator score to assess a stock’s technical strength or weakness. The score provides a comprehensive view of a stock’s potential price movement based on historical data and technical analysis. 

Disclosure

Related Articles
TheFlyMerck downgraded to Market Perform from Outperform at BMO Capital
TheFlyMicron sinks on guidance, TripAdvisor to buy Liberty TripAdvisor: Morning Buzz
TheFlyPersonalis receives $50M investment from Merck, extends pact with Moderna
Go Ad-Free with Our App